IL33 and bacterial arthritis: These clinical and experimental findings are consistent with the notion that the IL-33 levels are tightly regulated by sST2 availability (1, 4, 11, 57), suggesting that during S. aureus septic arthritis there is an enhanced availability and, potentially, activity of IL-33.